ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1391

Weight Loss and Risk of Death in Rheumatoid Arthritis

Joshua Baker1, Erica Billig2, Grant W. Cannon3, Liron Caplan4, Vikas Majithia5 and Ted R. Mikuls6, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 4Div of Rheumatology, Denver VA and Univ of Colorado School of Medicine, Aurora, CO, 5Div of Rheumatology, University of Mississippi Medical Center, Jackson, MS, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: morbidity and mortality, rheumatoid arthritis (RA) and weight loss

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Session Type: Abstract Submissions (ACR)

Background/Purpose

Low body mass index (BMI) has been linked to greater mortality among patients with Rheumatoid Arthritis (RA). Weight loss has also been associated with a greater risk of death among the elderly. The purpose of this study was to determine if weight loss is a predictor of death in RA.

Methods

Our sample consists of 1634 subjects from the Veterans Affairs Rheumatoid Arthritis (VARA) Registry. Dates of death were identified through review of the VA Computerized Patient Record System. BMI was extracted within 14 days of each visit and the change in BMI from the previous visit was determined. BMI category and weight change were considered time-varying. Weight loss at each visit was defined as a decrease in BMI of 1 kg/m2 from the preceding visit. Rate of loss (per 1 year) was defined as the change BMI from the preceding visit divided by the preceding interval length. Potential confounding co-variables associated with mortality in this cohort were identified. Cox proportional hazard models were used to assess associations between time-variant and time-invariant predictors of survival including the change in BMI and the rate of decline in BMI from the preceding visit adjusting for age, gender, race, BMI, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, smoking, and current use of methotrexate, prednisone, and anti-Tumor Necrosis Factor (TNF-α) medications. 

Results

Among 1634 subjects (280 deaths, 8102 patient-years, 17,057 unique observations), weight loss of 1 kg/m2 of BMI occurred in 2,308 observation periods (13.5%). Weight loss over the preceding interval was associated with an increased risk of subsequent death [HR: 2.00 (1.54, 2.60) p<0.001] (Table 1). In a subset of 1520 subjects with available data (223 deaths, 6650 patient-years), weight loss remained associated with an increased risk of death after further adjusting for CRP [HR 1.78 (1.33, 2.38) p<0.001] (full model not shown). In similar models, a rate of weight loss of >1 kg/m2 of BMI over a 6-month period was associated with a greater risk of death [HR: 1.74 (1.31, 2.32) p<0.001] while a slower rate of weight loss was not associated with an increased risk compared to those who did not lose weight [HR: 0.94 (0.70, 1.27) p=0.7].

Conclusion

Recent weight loss, particularly a loss of more than 1 kg/m2 of BMI (approximately 3.1 kg on average) over a 6-month period, is an independent predictor of death in RA. Changing weight may be a marker of poor functional status, poor nutrition, ongoing inflammation, and/or underlying malignancy and may help risk-stratify patients for more aggressive interventions.

Table 1:  Multivariable-adjusted risk of death among subjects with rheumatoid arthritis. (N=1634, Deaths=280, Person-Years=8,102)

Risk of Death

HR (95% CI)

Baseline Age

1.06 (1.04, 1.07)‡

Female

0.47 (0.23, 0.95)*

White

1.10 (0.82, 1.49)

BMI Category

   BMI <20 kg/m2

2.89 (1.99, 4.21)‡

   BMI 20-25 kg/m2

1 (reference)

   BMI 25-30 kg/m2

0.91 (0.67, 1.23)

   BMI >30 kg/m2

0.88 (0.61, 1.25)

Interval Weight Change

   < 1 kg/m2 loss

1 (reference)

   > 1 kg/m2 loss

2.00 (1.54, 2.60)‡

Current Therapies

   Methotrexate Use

0.59 (0.45, 0.76)‡

   Prednisone Use

1.40 (1.10-1.80)*

   TNF Use

0.73 (0.53, 1.01)

Baseline Comorbidities

   Diabetes

1.42 (1.09, 1.84)†

   Cardiovascular Disease

1.35 (1.05, 1.72)*

   Chronic Kidney Disease

1.89 (1.31, 2.73)‡

   COPD

1.73 (1.26, 2.36)‡

   Active Smoking

1.57 (1.16, 2.13)†

*p<0.05; †p<0.01; cm<0.001

Abbreviations: BMI= Body Mass Index; TNF= anti-Tumor Necrosis Factor Blocker Therapy; COPD= Chronic Obstructive Pulmonary Disease


Disclosure:

J. Baker,
None;

E. Billig,
None;

G. W. Cannon,
None;

L. Caplan,
None;

V. Majithia,
None;

T. R. Mikuls,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/weight-loss-and-risk-of-death-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.